Abstract |
Rationale: Magnetic resonance imaging (MRI) detects improvements in mucus plugging and bronchial wall thickening, but not in lung perfusion in patients with cystic fibrosis (CF) treated with elexacaftor/ tezacaftor/ivacaftor (ETI). Objectives: To determine whether bronchial artery dilatation (BAD), a key feature of advanced lung disease, indicates irreversibility of perfusion abnormalities and whether BAD could be reversed in CF patients treated with ETI. Methods: A total of 59 adults with CF underwent longitudinal chest MRI, including magnetic resonance angiography twice, comprising 35 patients with CF (mean age, 31 ± 7 yr) before (MRI1) and after (MRI2) at least 1 month (mean duration, 8 ± 4 mo) on ETI therapy and 24 control patients with CF (mean age, 31 ± 7 yr) without ETI. MRI was assessed using the validated chest MRI score, and the presence and total lumen area of BAD were assessed with commercial software. Results: The MRI global score was stable in the control group from MRI1 to MRI2 (mean difference, 1.1 [-0.3, 2.4]; P = 0.054), but it was reduced in the ETI group (-10.1 [-0.3, 2.4]; P < 0.001). In the control and ETI groups, BAD was present in almost all patients at baseline (95% and 94%, respectively), which did not change at MRI2. The BAD total lumen area did not change in the control group from MRI1 to MRI2 (1.0 mm2 [-0.2, 2.2]; P = 0.099) but decreased in the ETI group (-7.0 mm2 [-8.9, -5.0]; P < 0.001). This decrease correlated with improvements in the MRI global score (r = 0.540; P < 0.001). Conclusions: Our data show that BAD may be partially reversible under ETI therapy in adult patients with CF who have established disease.
|
Authors | Lena Wucherpfennig, Simon M F Triphan, Sabine Wege, Hans-Ulrich Kauczor, Claus P Heussel, Olaf Sommerburg, Mirjam Stahl, Marcus A Mall, Monika Eichinger, Mark O Wielpütz |
Journal | Annals of the American Thoracic Society
(Ann Am Thorac Soc)
Vol. 20
Issue 11
Pg. 1595-1604
(11 2023)
ISSN: 2325-6621 [Electronic] United States |
PMID | 37579262
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- elexacaftor
- ivacaftor
- tezacaftor
- Cystic Fibrosis Transmembrane Conductance Regulator
- Aminophenols
|
Topics |
- Adult
- Humans
- Young Adult
- Cystic Fibrosis
(diagnostic imaging, drug therapy)
- Bronchial Arteries
(diagnostic imaging)
- Dilatation
- Magnetic Resonance Imaging
- Cystic Fibrosis Transmembrane Conductance Regulator
- Mutation
- Aminophenols
|